Evaluation and Management of Graves' Orbitopathy

Otolaryngologic Clinics of North America

Volumn 39, Issue 5, 2006, Pages 923-942

  Lee, H B Harold ^a   Rodgers, I Rand ^b   Woog, John J ^a  

^a MAYO CLINIC   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC RECEPTOR BLOCKING AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; GUANETHIDINE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE;

ASEPTIC NECROSIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; BRAIN DISEASE; CATARACTOGENESIS; CENTRAL RETINA ARTERY OCCLUSION; COMPRESSION FRACTURE; CUSHINGOID SYNDROME; DECOMPRESSION SURGERY; DIGESTIVE SYSTEM ULCER; DIPLOPIA; DISEASE ASSOCIATION; DRY EYE; EMOTIONAL DISORDER; ENDOCRINE OPHTHALMOPATHY; EVALUATION; EXOPHTHALMOS; EYE IRRITATION; GASTROINTESTINAL HEMORRHAGE; GLAUCOMA; HEREDITY; HUMAN; HYPERTHYROIDISM; INFECTION; INTRAOCULAR PRESSURE ABNORMALITY; ORBIT INFLAMMATION; PATHOPHYSIOLOGY; RADIATION DOSE; RETINOPATHY; REVIEW; SIDE EFFECT; SLEEP DISORDER; SURGICAL TECHNIQUE; TUBERCULOSIS; VISUAL IMPAIRMENT; WEIGHT GAIN;

ADRENAL CORTEX HORMONES; GRAVES OPHTHALMOPATHY; HUMANS; OPHTHALMOLOGIC SURGICAL PROCEDURES;

EID: 33748577177     PISSN: 00306665     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otc.2006.07.008     Document Type: Review

References (50)

1. Dallow R.L., and Netland P.A. Management of thyroid-associated orbitopathy (Graves' disease). In: Albert D.M., and Jakobiec F.A. (Eds). Principles and practice of ophthalmology (2000), WB Saunders, Philadelphia (PA) 3082
2. Bartley G.B., Fatourechi V., Kadrmas E.F., et al. The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota. Am J Ophthalmol 120 4 (1995) 511-517
3. Gouch S.C. The genetics of Graves' disease. Endocrinol Metab Clin North Am 29 2 (2000) 255-266
4. Friedman J.M., and Fialkow P.J. Genetics of Graves' disease. Clin Endocrinol Metab 7 1 (1978) 47-65
5. Brix T.H., Kyvik K.O., Christensen K., et al. Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohrts. J Clin Endocrinol Metab 86 2 (2001) 930-934
6. Prabhakar B.S., Bahn R.S., and Smith T.J. Current perspective on the pathogenesis of Graves' disease and ophthalmopathy. Endocr Rev 24 6 (2003) 802-835
7. Weetman A.P., and Hunt P.J. The immunogenetics of thyroid-associated orbitopathy. Exp Clin Endocrinol Diabetes 107 Suppl (1999) S149-S151
8. Nunery W.R., Martin R.T., Heinz G.W., et al. The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease. Ophthalmic Plast Reconstr Surg 9 2 (1993) 77-82
9. Clague R., Mukhtar E.D., Pyle G.A., et al. Thyroid-stimulating immunoglobulins and the control function. J Clin Endocrinol Metab 43 (1976) 550
10. Bahn R.S. Pathophysiology of Grave's ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88 5 (2003) 1939-1946
11. Kazim M., Goldberg R.A., and Smith T.J. Insights into the pathogenesis of thyroid-associated orbitopathy. Arch Ophthalmol 120 3 (2002) 380-386
12. Rotella C.M., Zonefrati R., Toccafondi R., et al. Ability to monoclonal antibodies to the thyrotropin receptor to increase collagen synthesis in human fibroblasts: an assay which appears to measure exophthalmogenic immunoglobulins in Graves' sera. J Clin Endocrinol Metab 62 2 (1986) 357-367
13. Pritchard J., Horst N., Cruikshank W., et al. Igs from patients with Graves' disease induce the expression of T cell chemoattractants in their fibroblasts. J Immunol 168 2 (2002) 942-950
14. Valyasevi R.W., Harteneck D.A., Dutton C.M., et al. Stimulation of adipogenesis, peroxisome proliferatr-activated receptor-γ (PPARγ), and thyrotropin receptor by PPARγ agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab 87 5 (2002) 2352-2358
15. Kumar S., Leontovich A., Coenen M.J., et al. Gene expression profiling of orb ital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzles-related protein-1 in orbital adipogenesis. J Clin Endocrinol Metab 90 8 (2005) 4730-4735
16. Nunery W.R. Ophthalmic Graves' disease: a dual theory of pathogenesis. Ophthalmol Clin North Am 4 (1991) 73-88
17. Werner S.C. Classification of the eye changes of Graves' disease. J Clin Endocrinol Metab 29 7 (1969) 982-984
18. Werner S.C. Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab 44 1 (1977) 203-204
19. Kadrmas E.F., and Bartley G.B. Superior limbic keratoconjunctivitis. A prognostic sign for severe Graves' ophthalmopathy. Ophthalmology 102 10 (1995) 1472-1475
20. Migliori M.E., and Gladstone G.J. Determination of the normal range of exophthalmometric values for black and white adults. Am J Ophthalmol 98 (1984) 438
21. Feldon S.E., and Weiner J.M. Clinical significance of extraocular muscle volumes in Graves' ophthalmopathy: a quantitative computed tomography study. Arch Ophthalmol 100 (1982) 1266-1269
22. Char D.H., and Norman D. The use of computed tomography and ultrasound in the evaluation of orbital masses. Surv Ophthalmol 27 1 (1982) 49-63
23. Wall J.R., and How J. Graves' ophthalmopathy (1990), Blackwell Scientific, Boston (MA)
24. Bahn R.S., and Gorman C.A. Choice of therapy and criteria for assessing treatment outcome in throid-associated ophthalmopathy. Endocrinol Metab Clin North Am 16 (1987) 391-407
25. Prummel M.F. Graves' ophthalmopathy: diagnosis and management. [editorial]. Eur J Nucl Med 27 4 (2000) 373-376
26. Bartalena L., Marcocci C., Bogazzi F., et al. Use of corticosteroids to prevent progression of Graves' ophthalmopathy after radioactive iodine therapy for hyperthyroidism. N Engl J Med 321 (1989) 1349-1352
27. DeGroot L.J., Gorman C.A., Pinchera A., et al. Therapeutic controversies: radiation and Graves' ophthalmopathy. J Clin Endocrinol Metab 80 (1995) 339-349
28. Boyle I.T., Grieg W.R., Thompson J.A., et al. Effect of thyroid ablation on dysthyroid exophthalmos. Proc R Soc Med 62 (1969) 19-23
29. Bartalena L., Marcocci C., Tanda M.L., et al. Cigarette smoking and treatment outcomes in Graves' ophthalmopathy. Ann Intern Med 129 (1998) 632-635
30. Cartlidge N.E., Crombie A., Anderson J., et al. Critical study of 5% guanethidine in ocular manifestations of Graves' disease. BMJ 4 684 (1969) 645-647
31. Leone C.R. The management of ophthalmic Graves' disease. Ophthalmology 91 7 (1984) 770-779
32. Physicians' Desk Reference. 55th ed. (2001), Medical Economics Co. Inc., Montvale (NJ) p. 2110-1
33. Wakelkamp I.M., Baldeschi L., Saeed P., et al. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial. Clin Endocrinol (Oxf) 63 3 (2005) 323-328
34. Prummel M.F., and Weirsinga W.M. Immunomodulatory treatment of Graves' ophthalmology. Thyroid 8 6 (1998) 545-548
35. Wiersinga W.M. Immunosuppressive treatment of Graves' ophthalmopathy. Thyroid 2 3 (1992) 229-233
36. Brennan M.W., Leone Jr. C.R., and Janaki L. Radiation therapy for Graves' disease. Am J Ophthalmol 96 2 (1983) 195-199
37. Hurbli T., Char D.H., Harris J., et al. Radiation therapy for thyroid eye diseases. Am J Ophthalmol 99 6 (1985) 633-637
38. Gorman C.A., Garrity J.A., and Fatourechi V. A prospective, randomised, double-blind, placebo controlled study of radiotherapy for Graves' ophthalmopathy. Ophthalmology 108 9 (2001) 1523-1534
39. Mouritis M.P., van Kempen-Harteveld M.L., Garcia M.B.G., et al. Radiotherapy for Graves' orbitopathy: randomised, placebo controlled study. Lancet 355 (2000) 1505-1509
40. Parsons J.T., Bova F.J., Fitzgerald C.R., et al. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30 (1994) 755-763
41. Al-Mefty O., Kersh J.E., Routh A., et al. The long-term side effects of radiation therapy for benign brain tumors in adults. J Neurosurg 73 (1990) 502-512
42. Capo H., and Kupersmith M.J. Efficacy and complications of radiotherapy of anterior visual pathway tumors. Neuro-ophthalmology 9 (1991) 179-203
43. Goldsmith B.J., Rosenthal S.A., Wara W.M., et al. Optic neuropathy after irradiation of meningioma. Radiology 185 (1992) 71-76
44. Cheng S.W.K., Ting A.C.W., Wu P.H., et al. Accelerated progression of carotid stenosis in patients with previous external neck irradiation. J Vasc Surg 39 (2004) 409-415
45. Shorr N., and Seiff S. The four stages of surgical rehabilitation of the patient with dysthyroid ophthalmopathy. Ophthalmology 93 (1986) 476-483
46. Tarrus-Montaner S., Lucarelli M.J., Lemke B.N., et al. The surgical treatment of Graves' orbitopathy: a decade of progress. Ophthalmol Clin North Am 13 4 (2000) 693-704
47. Antoszyk J.H., Tucker N., and Codere F. Orbital decompression for Graves' disease: exposure through a modified blepharoplasty incision. Ophthalmic Surg 23 8 (1992) 516-521
48. Fatourechi V., Garrity J.A., Bartley G.B., et al. Graves' ophthalmopathy. Results of transantral orbital decompression performed primarily for cosmetic indications. Ophthalmology 101 5 (1994) 938-942
49. McCord C.D. Current trends in orbital decompression. Ophthalmology 92 1 (1985) 21-33
50. Olivari N. Transpalpebral decompression of endocrine ophthalmopathy (Graves' disease) by removal of intraocular fat: experience with 147 operations over 5 years. Plast Reconstr Surg 87 4 (1991) 627-641